. Transthoracic or transesophageal echocardiography are needed to diagnose the aoric stenosis, assess the let ventricular funcion, characterize the other valves, and determinate pulmonary pressure. These elements are of paramount importance for planning the procedure and straify the procedural risks (igure 1). Furthermore MSCT plays a crucial role in the screening of 
T ranscatheter aoric valve implantaion (TAVI) is a therapeuic alternaive to surgical aoric valve replacement (SAVR) or palliaive medical therapy for paients with symptomaic severe aoric valve stenosis (AVS) [1] [2] [3] [4] [5] . The high surgical risk for a paients with aoric valve stenosis has to be assessed jointly with the cardiac surgeon and the cardiac anaesthesiologist, as indicated in the guidelines for valvular heart disease management issued by the European society of cardiology in 2012 6 . Results from registries and trial are favourable with unexpected results of prosthesis performance and survival rate at 3 and 5 years of follow up [7] [8] [9] [10] [11] [12] [13] . TAVI carries higher risk of post procedural adverse events than convenional percutaneous cardiovascular intervenions, due to the baseline clinical condiion of the paients and to the associated comorbidiies.
Therefore, careful paient monitoring in a intensive care unit (ICU) during the irst 48 hours seems to be extremely important to early detect and manage complicaions, as well as decrease the rate of adverse events and the length of in-hospital stay.
Preprocedural paient assessment
Pre-procedure evaluaion include transthoracic echocardiography, invasive cardiac evaluaion with right and let cardiac catheterizaion, coronary angiography and cardiac and vascular mulislice computed tomography (MSCT). The baseline risk of the paients populaion is esimated by the logisic EuroScore, EuroScore II and STS-PROM score [14] [15] [16] [17] [18] . Adjuncive risk criteria, not included in these scores are frailty, porcelain aorta, severe liver disease/cirrhosis, hosile chest, severe right ventricle dysfuncion, chest radiaion, degeneraive neurological disorders, patent internal mammary artery or other criical conduits adherent to the sternum, severe right ventricle dysfuncion, or any contraindicaion to extracorporeal circulaion 19 paients candidate to TAVI. It allows careful evaluaion of the aoric valve apparatus: aoric valve morphology diameter and perimeter, calciicaion burden, annulus, let ventricular outflow tract, sinus of Vasalva height and length, coronary osia take of (Figure 2 and 3 ). This allows a correct sizing and the selecion of the beter prosthesis. Angio CT-scan of aorto-iliac and femoral arteries is important for choosing the opimal vascular access (igure 4), i.e, femoral route or alternaive, such as the trans-axillary/subclavian access, which consisted in a surgical exposure of the proximal part of the transaxillary artery, showing clear advantage in hosile vessel anatomies [20] [21] [22] [23] ; the trans-apical with surgical exposure of the let ventricular apex using customized introducer, balloon and device; and the last described approach, which is the trans-aoric one, requiring surgical access of the ascend- . Three dimensional reconstruction of the aorto-ilio-femoral axis; diameter and calciicaions can be analyzed using the transverse plane.
ing aorta. All these vascular routes showed to be safe in selected paients, with high procedural success and acceptable complicaion rate 24 . Once the paient is judged suitable for TAVI because all the clinical indicaion requirements (valvulopathy and surgical risk) have been satisfied and the aortic valve anatomy refereed suitable, it is necessary to evaluate the pre procedural clinical condiion, ruling out any pulmonary or urine infecions and hemocuagulaive disorder, and assess lung, renal and hepaic funcion, in order to be ready to face promptly any complicaions secondary to comorbidiies. A 24 hours ECG Holter monitoring is recommended to detect baseline rhythm disorders.
A standardized pre-medicaion regimen consists of aspirin 100 mg once daily and loading dose of Clopidogrel 300 mg on the day before the procedure. Prophylacic anibioic therapy is administered 24 hours before TAVI. Moreover, two units of concentrated red cells are reserved in consideraion for the possibility of haemorrhagic complicaions. The prosthesis frame is comprised of three disinct regions that interact with the aoric root at diferent levels (igure 5). The lower inlow porion has high radial strength for facilitaing device anchoring. The constrained middle porion incorporates the valve lealets and has the smallest diameter to avoid coronary osial jailing. The ouflow porion serves to orient the frame to the direcion of blood low in the ascending aorta.
Device and procedure descripion
The procedures are performed with surgical back up, under luoroscopic guidance, and in a standard cardiac catheterizaion laboratory.
The anaesthesiological management is chosen basing on the paient condiion. In our center analgo sedaion without endo-tracheal intubation is the preferred approach for the following reasons: more stable hemodynamic of the paient, spontaneous breathing, shorten in-ICU stay and reduction in post procedural pulmonary disorders. Further extubaion ime in case of general anaesthesia and tradiional endo-tracheal intubaion is an unpredictable factor, especially for elderly people who have lung diseases and other severe comorbidiies. General anaesthesia is the preferenial way during transaoric or transapical access, or other accesses when transesophageal ehcoacardiographic monitoring is required. For adequate paient monitoring during the intervenion it is always recommended a central venous catheter (CVC) placed in the right jugular vein or let subclavian vein in all paients for drug delivery, luid administraion and monitoring of central venous pressure (CVP). A radial artery cannula for invasive pressure measurement is usually placed. The worst femoral access is chosen for the 5 Fr diagnosic pig tail catheter. A temporary pacing is posiioned in the right ventricular (RV) apex through a venous access.
Vascular accesses preparaion
Vascular accesses can be obtained in percutaneous fashion for the transfemoral, when preclosure percutaneous systems are available like Prostar XL 10 F (Abbot Vascular Devices, Redwood City, C) or with surgical exposure in all the others. There are advantages and disadvantages for both approaches. Surgical exposure is recommended for complex vascular anatomy and for transaxillary artery, increasing the procedural ime and the in-hospital stay but reducing vascular complicaions.
The femoral artery for inserion of the 18Fr introducer (selected ater reviewing CT images) is accessed under angiographic guidance. The principal points are the following: 1) A 9Fr introducer is inserted into the common femoral artery.
2) Ater conirming access, the 9Fr introducer is removed over a 0.035" J-wire and a 10Fr-Prostar -XL device is inserted and all four sutures are harvested in a Preclose fashion.
3) The 9Fr introducer is reinserted and a super-sif Amplatz wire (SSA-1) is placed in the aorta.
4) An 18Fr introducer is then advanced under luoroscopy over the SSA-1 wire above the level of the aoric bifurcaion.
If surgical exposure of femoral artery is performed, ater femoral artery exposure and the 9 F introducer inserion only the points 3 and 4 are performed. , MN, USA ) . The prosthesis frame consists of three disinct regions: the lower inlow porion that has high radial strength for facilitaing device anchoring; the constrained middle porion, which incorporates the valve lealets and has the smallest diameter to avoid coronary osial jailing and the ouflow porion serving to orient the frame to the direcion of blood low in the ascending aorta .
When femoral access with the 18Fr introducer is contraindicated, the let distal axillary artery with surgical exposure can be used as alternaive route 25 . The let arm is ixed in a posiion of abducion and external rotaion at 90° degrees. A skin and deep-issue incision is then made along a line that follows the course of the artery originaing from the apex of the axilla and projecing itself into the crook of the elbow. The axillary artery is exposed upstream and downstream to the puncture site. Ater isolaion, the artery is accessed with a18 G needle and a 7Fr introducer is advanced over a 0.035" 145 cm j-ip standard guide wire. A 5Fr pigtail catheter is posiioned in the ascending aorta above the aoric valve plane and the standard guide wire is exchanged for SSA-1 wire (Boston Scieniic Corp). A small transverse nick is made in artery wall and the 18-Fr introducer is advanced ill the distal radiopaque marker is protruding at least 10 mm in the aoric arch (igure 6). The proximal part of the introducer is secured to the skin with a 00 silk suture .
Implantaion technique
Ater crossing the naive aoric valve with a standard diagnosic Amplatz let (AL-1) catheter and straight ip wire, a SSA-1 wire with a hand shaped loop at the end is placed in the let ventricular apex in stable posiion using the right anterior oblique projecion. A pre-implantaion balloon aortc valvuloplasty is rouinely performed under rapid RV pacing with an undersized balloon for preparing the naive annulus except in pure aoric regurgitaion or degenerated aoric bioprosthesis (igure 7).
The CoreValve implantaion is performed as follow: a 5 fr diagnosic pigtail catheter is posiioned in the noncoronary cusp as a marker for the annular plane and for contrast injecions during the valve release. The image intensifier is positioned in the optimal left anterior oblique (LAO) projecion for aligning all three coronary cusps in a straight line. The delivery catheter system (DCS) is posiioned such that one horizontal markers of the device is posiioned below the level of the pigtail catheter and the release is iniiated under luoroscopic and angiographic guidance with repeated small contrast injecions (10 cc to 10 cc/sec at 900 psi) through the pigtail catheter. The DCS frame must be posiioned 4 to 6 mm below the annular plane prior to iniiaing release of the valve frame; the release of the valve must be performed very slowly making small adjustments for compensaing undesired movement; he DCS is maintained in as central a posiion as possible in the aoric root, Ater the prosthesis is released completely, the release hooks of the device are carefully observed to ensure their detachment from the DCS in LAO and right anterior oblique projecion projecions.
Post deployment, hemodynamic measurements and ascending aortogram must be performed to assess for presence and severity of para-prostheic regurgitaion (PPR).
How to assess a paravalvular leak
When a paravalvular leak is observed ater implantaion the operator should accurately evaluate the severity of the PPR, and understand the underlying mechanis . The severity of the regurgitaion must be assessed using hemodynamic measurements, angiographic and echocardiographic evaluaion.
The simultaneous recording of aoric pressure and let ventricular (LV) pressure gives a lot of informaion. When the diastolic aoric pressure is below 40 mmHg and the LV end-diastolic pressure is higher than baseline the aoric regurgitaion is likely to be severe and must be corrected (igure 8). The aortography should be performed with adequate volume and rate of contrast in- jecion in two orthogonal views in order to quanify the severity of regurgitation, identify the location and mechanism of the leak, understanding if it occurred for incomplete prosthesis expansion or incomplete apposiion. In this case the inlet porion of the valve is few millimeter far away from the calciied annulus only under one cups for the presence of a calciicaion, or in muliple locaions because undersized valve.
If there is a low valve malposiion the mechanism of leak is a inadequate sealing of the inlet porion of the CoreValve, so the blood returns in the ventricle passing through the struts above the upper part of the pericardium skirt, When there is an high valve malposiion we can have severe regurgitaion and /or coronary osia obstrucion by the inlet part of the prosthesis.
The trans-thoracic echocardiography is a useful diagnosic tool, when the acousic window is opimal, and using the three main views (parasternal long axis, parasternal short axis and the apical ive chamber), it is possible to understand the posiion and extension of the leak, the severity of regurgitaion and the impairment of the LV (igure 9). If there is a under expansion of the valve, or malapposiion of one side of the valve, balloon post dilataion is recommended during a careful right ventricular pacing for reducing the let ventricular systolic pressure in order to obtain a stable balloon posiion. If the valve is too high, the irst maneuver is to snare the valve from one of the two hooks and pull the valve in the ascending aorta, because the danger of coronary low obstrucion. Then place a second valve. The so called "valve-on-valve", does not impair the device funcion . If the valve is too low try to pull the valve of few mm using a snare with a "pull and stop" technique: the snare is inserted from one of the femoral artery, and one of the two hooks is catched and start pulling ill when the beaing heart is felt ,the stop and maintain the posiion, wait few minutes and then start again 26 . Someimes the femoral approach is not uncomfortable for snaring the valve, in this case from an artery access from the let arm (radial or brachial) for obtaining a beter catheter snare direcion of tracion 27 . If this maneuver is inefecive, the "valve-in-valve" technique is the second opion, placing a second valve within the irst 28, 29 .
Once the prosthesis is successfully deployed, removal of vascular catheters is carried out in the catheterizaion laboratory. The temporary pacemaker electrode placed into the right ventricle through a femoral vein is maintained for 24-48 hours.
Post procedural Intensive care management
The post-operaive care is challenging because of the incidence of procedural and post procedural life threatening complicaions related to the invasiveness of TAVI and to the abrupt hemodynamic changes occurring after the sudden relief of valvular obstrucion in paients with a chronically low cardiac output state 30 . Ater the procedure all paients are rouinely transferred to the ICU. During the irst 48 hours, vital parameters are coninuously monitored by a nurse. Close attenion has to be given to rhythm and atrio-ventricular conducion disturbances, systemic blood pressure and luid balance, monitoring diuresis and adjusing intravenous luid administraion in order to maintain CVP between 5 to 10 mmHg. Oxygen saturaion values are obtained from transcutaneous pulse oximetry, with arterial blood gas test when necessary Assessment of cardiologic symptoms, such as palpitaions, chest pain, faigue and shortness of breath, and examinaion of mental status, including consciousness, orientaion and memory, require a careful observaion of paients for the early detecion of signs of acute heart failure or neurological deicit.
Vascular accesses and peripheral pulses are monitored for hematoma, pseudo-aneurysm or acute thrombosis. When necessary a peripheral echo-Doppler is performed.
To prevent infecions, stringent cleaning of vascular accesses and care of urinary catheter are daily advised. If signs of systemic infecion are present, blood and/or urinary cultures are ordered.
Laboratory tests are performed daily and consisted in: blood routine count for detecting signs of occult bleeding, infecion, dual aniplatelet therapy intolerance or heparin induced thrombocytopenia and for the assessment of renal funcion to diagnose acute kidney insuiciency (AKI) deined as a decrease of > 25% in eGFR at 48 hours following the procedure or the need of haemodialysis during hospitalizaion [31] [32] [33] [34] [35] . The degree of AKI is further classiied as: (i) mild (> 25% decrease in eGFR); (ii) moderate (50-75% decrease in eGFR), and (iii) severe (>75% decrease in eGFR). (36) Other rouine laboratory test included: electrolytes serum concentraions, liver and muscular enzymes and cloing parameters.
A trans-thoracic echocardiogram is planned 6 hours ater TAVI and then every 24 hours, to assess opimal posiion of the prosthesis, trans-prostheic gradient, paravalvular leak or aoric regurgitaion, mitral valve and let ventricular funcion, systolic pulmonary arterial pressure and pericardial efusion.
Standard medical therapy include low molecular weight heparin unil ambulaion, appropriate anibioic therapy for three days, acetylsalicylic acid (100mg) and Clopidogrel (75mg) daily; inotropic support, anihypertensive and diureic therapy if needed.
Early paient ambulaion, within 24/48 hours, is encouraged to prevent complicaions, such as muscle atrophy, consipaion, decubitus ulcers, thrombo-phlebiis and to reduce length of hospital-stay. Paients should undergo physical rehabilitaion just ater mobilizaion and pulmonary rehabilitaion in paients with pulmonary diseases expecially in case of intra-procedural endo-tracheal intubaion.
Renal failure. Chronic kidney disease is a predisposing factor for post-procedural AKI (30) (31) (32) (33) (34) (35) . However, paients with normal baseline renal funcion can develop post-procedural AKI despite a low volume of contrast medium used. These paients can have an intense polyuric phase soon ater TAVI, followed by an oliguric status. The mechanism can be the sudden decrease in heart illing pressures matched to a signiicant increase in cardiac output and kidney perfusion just ater valve implantaion. This polyuria is followed by intravascular volume reducion, conirmed by a marked drop in CVP, which led to a prerenal acute renal failure. Therefore, a careful monitoring of the luid balance with coninuous CVP measurement and intravenous volume repleion to correct luid loss is mandatory to lower the rate of AKI. When pre-renal acute renal failure occurs protocol for luid replacement therapy tailored to maintain the CVP value between 5 to 10 mmHg.
Diureics have to be administered only in those paients with low let ventricular ejecion fracion, severe LV diastolic dysfuncion, coexistence of severe mitral regurgitaion and RV dysfuncion with severe pulmonary hypertension; also paients with persistent oliguria despite opimizaion of intravascular volumes and cardiopulmonary hemodynamics could beneit from diureic drugs.
Vascular complicaions. Femoral artery pseudoaneurism (FAP) is the most common vascular complicaion ater TAVI. Physical examinaion of vascular accesses sites and peripheral pulses have to be systemaically performed every 3 hours looking for bleeding, pulsaile hematoma or acute signs of limb ischemia. Color Doppler ultrasound scanning can be performed in cases of groin pulsaile masses to conirm or to exclude the presence of FAP. Manual compression repair under ultrasound monitoring signiicantly reduce the need for surgical repair of FAP, leading to early paient ambulaion and short hospital stay. Surgical vascular intervenion is the preferred as irst-line treatment in paients with signs of acute haemodynamic compromission or if manual compression failed (30, 37) .
Conducion Disturbances. These frequently consist in Let Bundle Branch Block (LBBB), or advanced or complete atrio-ventricular block (AVB) within the irst 24 hours of TAVI. Complete AVB is a potenial acute and late complicaion of TAVI. It is hypothesized that coninued prosthesis expansion can cause a mechanical trauma to the conducion system, paricularly in paients with calciied aoric annulus, worsening pre-exising conducion defects or generaing new ones. The atrioventricular node is in fact in close proximity to the subaoric region and membranous septum of let ventricle ouflow tract. Therefore proper posiioning of the prosthesis within the let ventricular ouflow tract may limit risk of conducion abnormaliies and potenially the need for pacing [39] . It is now recommended to posiion the proximal end of the valve frame < 6 mm from the lower edge of the noncoronary cusp. Permanent pacemaker implantation is recommended as early as possible.
Cerebrovascular accident is a rare complication, ranging from 2 to 4 % (7-12, 40,41) , they occur intraprocedurally, and mostly are minor stroke. Severe aoric arch calciicaionscan be a source of increased embolizaion during wire manipulaion, catheter exchanges in aorta and when the device is retrieved and then reposiioned. In this case the lared distal part of the prosthesis can scratched the atheromatous aoric wall resuling in cerebral micro-embolizaion.
Thrombocytopaenia usually is caused by anicoagulant therapy, as conirmed by the rapid and spontaneous resoluion ater heparin withdrawal (42) . The use of fondaparinux as thromboembolic prophylaxis is atracive and we recently introduced in postoperaive protocol as rouine anicoagulaion . All these data emphasize the importance of a strict platelet count control.
Currently, the opimal anithromboic prophylaxis remains embroiled in controversies (43, 44) . About Corevalve prosthesis, it is only speculated that before the process of endothelizaion, the risk of thrombosis induced by the prosthesis is high and that dual antiplateled therapy should be advocated for at least the irst three months ater the implantaion. However, taking into account that there are no reports on embolic events ater TAVI, the perceived high risk of developing valve thrombosis and systemic thromboembolism may not be real. Our experience shows that the use of dual aniplatelet therapy is to some extent "empirical" and that in selected paients, without unstable coronary artery disease, the long-life use of aspirin is effective, more economic and possibly beter tolerated by pa-ients. Ater TAVI dual aniplatelet therapy with aspirin and clopidogrel for three up to six months is currently recommended, but there is no scieniic evidence supporting this strategy (43) . Therefore antithrombotic therapy with aspirin alone can be ofered in those paients at high risk of major bleeding
Conclusions
TAVI is a novel technique for the intervenional cardiologist, which requires a careful assessment of the clinical condiions of candidate paients in order to have a safe and efecive procedure. The post-operaive care needs a level of atenion higher than other percutaneous intervenions, due to the high-risk characterisics of this paient populaion such as advanced in age, frailty and comorbidiies. The potenial complicaions are known, but a standardized monitoring and management protocol and a speciic training of caregivers would be useful for the early recogniion and treatment of complicaions, which will result in a more favourable outcome.
